JOHN D SHULMAN

CIK 1208886 · Managing Director · last filed 2026-07-09

JOHN D SHULMAN is a Managing Director who has filed 18 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider bought $110.0K of WRAP on Jul 9, 2026. Across all open-market trades the lifetime net is +$7.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $776.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$776.8K

Companies

3

Total Filings

18

Lifetime Open-Market Net

$7.63M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
WRAP	Director	449,037	$1.73	$776.8K	$110.0K	6	2026-07-09
Petros Pharmaceuticals, Inc. (PTPI) Delisted	Director	22,231	$0.01	$138	$7.50M	3	2021-11-30
ALLIED CAPITAL CORP (ALD) Delisted	Managing Director	178,482	—	—	$24.5K	9	2008-12-04

Recent Filings

18 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-07-09	WRAP	Buy (P)	+100,000	$110.0K	EDGAR
2026-07-06	WRAP	Grant (A)	—	$0	EDGAR
2026-05-04	WRAP	Grant (A)	+19,643	$0	EDGAR
2026-02-03	WRAP	Grant (A)	+250,000	$500.0K	EDGAR
2026-01-05	WRAP	Grant (A)	+9,394	$0	EDGAR
2025-12-29	WRAP	Grant (A)	—	$0	EDGAR
2021-11-30	Petros Pharmaceuticals, Inc. (PTPI) Delisted	Buy (P)	+2,500,000	$7.50M	EDGAR
2021-04-09	Petros Pharmaceuticals, Inc. (PTPI) Delisted	Grant (A)	—	$0	EDGAR
2020-12-03	Petros Pharmaceuticals, Inc. (PTPI) Delisted	Grant (A)	+3,382,416	$0	EDGAR
2008-12-04	ALLIED CAPITAL CORP (ALD) Delisted	Buy (P)	+10,000	$24.5K	EDGAR

Showing 1–10 of 18

Page 1 of 2 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.